Person

William D. Young

Formerly Director, Vertex Pharmaceuticals

Current S&P 500 boards
0
Current roles
0
Open-market buys
$0
Open-market sales
$10.9M

Current roles

From Section 16 filings (Forms 3, 4 and 5) in the last 13 months.

No current S&P 500 role.

Past roles

“Last filing” is the latest Form 3/4/5 for that company, an upper bound on the end date.

Sits alongside

People who currently share a board or management team with this person.

No current colleagues on record.

Open-market trades

Purchases and sales reported on Form 4 at S&P 500 companies.

DateCompanyTypeSharesPriceValue
Jan 2, 2020VRTXSale10,134$219.37$2.2M
Jan 2, 2020VRTXSale100$220.08$22K
Jan 2, 2020VRTXSale7,266$218.73$1.6M
Jan 2, 2020VRTXSale2,500$217.72$544K
Dec 30, 2019VRTXSale500$220.25$110K
Dec 30, 2019VRTXSale300$221.16$66K
Dec 30, 2019VRTXSale7,402$218.05$1.6M
Dec 30, 2019VRTXSale21,798$218.93$4.8M

SEC reporting-owner ID (CIK) 1217420 · all filings on EDGAR

William D. Young | USBoard